More Than Half of American Adults with Multiple Sclerosis Report Mistreatment by Caregivers
February 10th 2021Patients with multiple sclerosis who rely on family members as caregivers may be at particular risk for mistreatment, as those caregivers struggle to balance work, childcare, and health concerns of their own.
Read More
FDA Issues EUA for Monoclonal Antibodies as Treatment for COVID-19
February 10th 2021A clinical trial of patients with COVID-19 at high risk for disease progression showed that a single intravenous infusion of bamlanivimab and etesevimab together significantly reduce COVID-19-related hospitalization and death.
Read More
Study: US Adults Report Highest Stress Level Since Early Days of COVID-19 Pandemic
February 9th 2021Moreover, 9 in 10 adults say that they hope the country moves toward unity, according to Stress in America: January 2021 Stress Snapshot, conducted by The Harris Poll on behalf of the American Psychological Association (APA).
Read More
FDA Grants Breakthrough Therapy Designations for Investigational STAMP inhibitor in CML
February 9th 2021The BTD designations for asciminib were based on the phase 3, multicenter, open-label, randomized ASCEMBL trial and a phase I trial that included patients with Ph+ CML, some of them harboring the T315I mutation.
Read More
FDA Approves Breyanzi for Adults with Relapsed, Refractory Large B-cell Lymphoma
February 8th 2021Of 192 study participants who received Breyanzi, 73% achieved a response, including 54% who had minimal or no detectable lymphoma remaining following treatment and 19% who achieved a partial response.
Read More
Medicaid Expansion Helped Identify Undiagnosed HIV Infections, Increased Prevention Services
February 8th 2021In order to eradicate HIV, the researchers said increasing health coverage will be essential. Without that, HIV will continue to spread, and individuals will be unaware of their status.
Read More
Report Shows 125,000 Fewer US COVID Deaths if 50% Initiate Vaccination by March 1
February 8th 2021The report, developed by Thomas McAndrew, a computational scientist and faculty member at Lehigh University's College of Health, and colleagues, uses data from experts and trained forecasters, combining their predictions into a single consensus forecast.
Read More
FDA Grants Accelerated Approval to Treatment for Marginal Zone Lymphoma, Follicular Lymphoma
February 8th 2021The FDA has granted an accelerated approval to umbralisib for the treatment of select patients with relapsed/refractory marginal zone lymphoma and relapsed/refractory follicular lymphoma.
Read More
NACDS Urges Congress to Recognize Critical Role of Pharmacies in Overcoming the Pandemic
February 5th 2021In a recent congressional hearing, the NACDS submitted a statement underscoring the critical role of pharmacies, pharmacists, and pharmacy teams in the COVID-19 response and recovery efforts taking place across the country.
Read More